Viewing nowCombinationTriinone Tablets 40/5/10mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
DaeWon Pharmaceutical Co., Ltd.

MFDS item code 201802227 · Approved 2018.05.30 · Insurance code 671806620
Treatment of hypertension and dyslipidemia; inhibition of the progression of atherosclerosis and cardiovascular disease risk
This drug is used for patients with essential hypertension who have difficulty controlling blood pressure while taking a combination of telmisartan and amlodipine, and who also need to take rosuvastatin. Telmisartan and amlodipine help effectively control blood pressure, while rosuvastatin regulates hypercholesterolemia and various types of dyslipidemia to slow the progression of atherosclerosis. Additionally, rosuvastatin reduces the risk of cardiovascular diseases and helps decrease the risks of stroke, myocardial infarction, and arterial revascularization. Therefore, this drug is used to improve the condition of patients requiring simultaneous management of blood pressure and cholesterol.
This medication should be taken once daily as one tablet with water, regardless of meals. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). This medication is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking a telmisartan/amlodipine combination and rosuvastatin as separate products, they may be switched to this medication (a combination product containing the same amounts of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended that the dose of each individual component (amlodipine or telmisartan) be adjusted. However, if blood pressure is not controlled with the individual components, switching directly to a telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medication 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medication 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients taking rosuvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, regardless of meals. The initial dose is 5 mg once daily; if a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 mg per day. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, whereas an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients. In a drug interaction study of the active ingredients of this medication, telmisartan/amlodipine 80/10 mg and rosuvastatin 20 mg, in the presence of telmisartan/amlodipine, rosuvastatin Cmax increased approximately 2.4-fold and AUC increased approximately 1.3-fold. Therefore, when administering this medication, the potential risk associated with the increase in rosuvastatin Cmax should be assessed, and patients should be monitored closely.
This drug can cause serious harm to the fetus and newborn in pregnant women, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug's ingredients or similar medications, or those with certain conditions such as severe liver impairment, severe kidney impairment, or a history of angioedema should not use this medication. Elderly patients, those with hypotension, patients with impaired liver or kidney function, and those with a history of muscle-related diseases should use this drug cautiously, and if necessary, require careful monitoring by a physician. If muscle pain, weakness, or cramps occur while taking this medication, consult a physician immediately. If these symptoms are severe or if blood tests show a significant increase in muscle enzyme levels, stop taking the drug. Since liver function abnormalities may occur, regular liver function tests should be conducted before and during treatment; if liver enzyme levels rise significantly, the medication should be discontinued. As this medication lowers blood pressure, symptoms of hypotension or dizziness, fainting may occur, so caution is necessary when driving or operating machinery. Be aware of potential interactions with other drugs; if currently taking other medications, inform your physician or pharmacist, especially when taking potassium-sparing diuretics, potassium supplements, certain antibiotics, and immunosuppressants. This medication is not recommended for breastfeeding women; if it is necessary to take it, breastfeeding should be discontinued. In case of overdose, symptoms may include hypotension, dizziness, and heart rhythm abnormalities; seek medical attention immediately for appropriate treatment. It is not advisable to use this medication in children as safety and efficacy have not been adequately established, and older adults should take it with caution, adjusting the dose as necessary. Keep this medication out of reach of children and do not transfer it to another container.
Viral upper respiratory infection, dyspnea, rectal bleeding, dyspepsia, atopic dermatitis, peripheral edema, chronic gastritis, various gastrointestinal disorders, hiatal hernia, infections, fungal infections, abscesses, otitis media, erectile dysfunction, back pain, sinusitis, diarrhea, pharyngitis, allergies, fever, leg pain, fatigue, palpitations, dependent edema, angina, rapid pulse, leg edema, abnormal ECG, insomnia, drowsiness, migraine, dizziness, sensory disturbance, involuntary muscle contraction, sensory loss, flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, nonspecific gastrointestinal disorders, gout, hypercholesterolemia, diabetes, arthritis, arthralgia, leg numbness, anxiety, depression, nervous hypersensitivity, asthma, bronchitis, rhinitis, nosebleeds, dermatitis, rash, eczema, itching, angioedema, frequent urination, cystitis, cerebrovascular disease, visual disturbances, conjunctivitis, tinnitus, ear pain, headache, dizziness, flushing, palpitations, arrhythmia, bradycardia, chest pain, peripheral ischemia, syncope, orthostatic hypotension, vasculitis, peripheral neuropathy, tremors, loss of appetite, dysphagia, pancreatitis, gingival hyperplasia, asthenia, burning sensation, fatigue, pain, rigidity, weight gain, weight loss, osteoarthritis, muscle cramps, sexual dysfunction, insomnia, abnormal dreams, depersonalization, angioedema, polymorphic erythema, diplopia, ocular pain, nocturia, dry mouth, increased perspiration, hyperglycemia, thirst, leukopenia, purpura, thrombocytopenia, skeletal pain, osteoporosis, sensory loss, movement disorders, tinnitus, hearing loss, halitosis, fatty liver, angioedema, hypersensitivity reactions, fever, lower limb edema, thrombocytopenia, increased uric acid, liver function abnormalities, liver disease, acute renal failure, anemia, elevated CPK, anaphylactic reactions, tendon pain, rhabdomyolysis, headache, asthenia, cough, fatigue, weakness, facial edema, angioedema, itching, rash, urticaria, myalgia, myopathy, asthenia, constipation, nausea, abdominal pain, skeletal pain, arthralgia, sensory disturbances, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, memory impairment, forgetfulness, amnesia, memory disorders, confusion
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to light and should be stored in a container that protects it from light. It is also important to store it at room temperature between 1 and 30 degrees Celsius to maintain its effectiveness.
Pink oval film-coated tablet
30 tablets (10 tablets x 3) / PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
DaeWon Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.